EXPRES2ION BIOTECHNOLOGIES
Similar Organizations
Guardian Biotechnologies
Guardian Biotechnologies is a biotechnology company.
Protein Technologies
Protein Technologies Ltd. (PTL) is an award-winning, biotech company.
Current Advisors List
More informations about "ExpreS2ion Biotechnologies"
Company - ExpreS2ion Biotechnologies
Board at ExpreS2ion Biotechnologies ApS. Dr. Jensen has been an independent member of the board since the Company’s IPO in 2016. Shares: Dr. Jensen owns 707,457 shares in …See details»
ExpreS2ion Biotechnologies - Wikipedia
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden. ExpreS2ion is part of the PREVENT-nCoV consortium comprising AdaptVac (a joint-venture between ExpreS2ion Biotechnologies and the University of CopenhagenSee details»
ExpreS2ion - Crunchbase Company Profile & Funding
ExpreS2ion is a biotechnology company that develops innovative vaccines for a healthier world. We want to transform healthcare by developing novel vaccines, that are life-saving and …See details»
ExpreS2ion Biotechnologies - innovative vaccines for a healthier …
ExpreS2ion BIOTECHNOLOGIES APS ExpreS2ion Biotechnologies ApS was founded in 2010 and is the Group’s operating subsidiary. It is 100% owned by ExpreS2ion Biotech Holding AB. …See details»
Proteins for life - ExpreS2ion Biotechnologies
Organization to extend the ompany’s runway. Unfortunately, this meant parting ways with talented colleagues who have ... EXPRES2ION BIOTECHNOLOGIES APS ExpreS2ion …See details»
ExpreS2ion Biotechnologies ApS - Drug pipelines, Patents, Clinical ...
Explore ExpreS2ion Biotechnologies ApS with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, and 6 literature, Disease Domain ...See details»
Proteins for life - ExpreS2ion Biotechnologies
ExpreS2ion Biotechnologies ApS was founded in 2010 on the realisation that to produce the complex proteins needed for biological drugs and vaccines of the future, in a safer and more …See details»
ExpreS2ion Biotech Holding AB (publ) (STO: EXPRS2) Company …
Sep 20, 2024 ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in …See details»
Expres2ion Biotechnologies - VentureRadar
ExpreS2ion Biotechnologies is a world leading CRO biotech company within protein production in Drosophila Schneider-2 (S2) cells. Our company has a proprietary and complete S2 …See details»
ExpreS2ion Biotechnologies: Full commitments from members of …
Hørsholm, Denmark, 21 November 2024 - ExpreS2ion Biotech Holding AB's ("ExpreS2ion" or the "Company") announces that all members of the Company’s Board and Management holding …See details»
Disease focus - ExpreS2ion Biotechnologies
New research led by the World Health Organization has found that vaccines have saved an estimated 154 million lives in the past 50 years from 14 different diseases. ... ExpreS2ion …See details»
ExpreS2ion Biotechnologies - innovative vaccines for a healthier …
EXPRES2ION 2023 YEAR-END REPORT Company structure ExpreS2ion Biotech Holding AB is a limited company which has been listed on the Nasdaq First North Growth Market in Sweden …See details»
ExpreS2ion Biotechnologies – production in Drosophila S2 cells
ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 …See details»
ExpreS2ion strengthens its organization to further accelerate its ...
Jan 11, 2021 ExpreS2ion strengthens its organization to further accelerate its pipeline project development Mon, Jan 11, 2021 08:30 CET Report this content Hørsholm, Denmark, January …See details»
ExpreS2ion to present in upcoming investor and scientific events
Oct 31, 2024 About ExpreS2ion ExpreS2ion is a biotechnology company that develops innovative vaccines for a healthier world. We want to transform healthcare by developing novel …See details»
ExpreS2ion Biotech – A look back at 2024 with CEO | Placera
Dec 18, 2024 Together with ExpreS2ion Biotechnologies' CEO, Bent Frandsen, we looked back at the main achievements in 2024, which was the first year of implementing the new strategy. …See details»
Proprietary Pipeline - ExpreS2ion Biotechnologies
ExpreS2ion Biotechnologies ApS: CVR/VAT: DK32770487 Agern Allé 1 DK-2970 Hørsholm, Denmark Contact: [email protected] +45 22 22 10 19. Holding Company ExpreS2ion …See details»
ExpreS2ion Biotechnologies - Cision News
ExpreS2ion is a biotechnology company that develops innovative vaccines for a healthier world. We want to transform healthcare by developing novel vaccines, that are life-saving and …See details»
ExpreS2ion Biotechnologies Aps - DevelopmentAid
ExpreS2ion Biotechnologies Aps — Consulting Organization from Denmark, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Research, Science & Innovation sectorsSee details»